Job/Unit: O30616
/KAP1
Date: 15-07-13 12:31:59
Pages: 10
Luminescent 2-(2Ј-Hydroxyphenyl)benzoxazoles
7.56–7.60 (m, 1 H, CH Ar), 7.52 (d, J = 6.9 Hz, 2 H, CH Ar), 7.49
(d, J = 6.6 Hz, 2 H, CH Ar), 7.41 (d, J = 12.6 Hz, 4 H, CH Ar),
7.33–7.39 (m, 2 H, CH Ar), 2.57 (s, 3 H, CH3), 1.36 (s, 18 H,
CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 168.9, 158.9, 152.4,
152.1, 150.3, 149.3, 141.9, 137.9, 132.5, 131.5, 125.8, 125.5, 125.5,
124.8, 122.3, 121.4, 120.7, 120.6, 120.6, 119.7, 119.5, 110.6, 95.7,
91.1, 86.5, 82.5, 34.9, 31.2, 21.1 ppm. C39H35NO3 (565.71): calcd.
C 82.80, H 6.24, N 2.48; found C 82.69, H 5.84, N 2.13. MS (EI):
m/z (%) = 565.1 (100).
(m, 8 H, CH2), 0.97 (t, J = 7.2 Hz, 12 H, CH3) ppm. 13C NMR
(75 MHz, CDCl3): δ = 162.2, 158.1, 149.2, 148.1, 148.0, 139.8,
139.0, 133.1, 132.8, 128.8, 125.7, 125.1, 119.4, 115.8, 114.2, 111.3,
111.2, 110.8, 110.7, 108.7, 108.7, 96.4, 90.0, 85.6, 81.9, 50.7, 29.4,
20.4, 14.0 ppm. C46H55NO2 (653.95): calcd. C 81.02, H 8.13, N
6.16; found C 80.87, H 7.44, N 6.04. MS (EI): m/z (%) = 665.2
(100).
HBO Borate Complex 9: To a stirred solution of HBO 7 (100 mg,
0.19 mmol) in freshly distilled dichloromethane (10 mL) was added
BF3·OEt2 (0.14 mL, 1.1 mmol) by syringe under an argon atmo-
sphere. After 5 min, DIEA (0.19 mL, 1.1 mmol) was added, and
the resulting mixture was stirred at room temperature for 1 h. The
crude solution was then filtered through a column of basic Al2O3
(CH2Cl2), and the solvent was evaporated in vacuo. Pure HBO bor-
2-(Benzoxazol-2-yl)-4,6-bis{[4-(dibutylamino)phenyl]ethynyl}phenyl
Acetate (6): To a solution of p-(di-n-butylamino)phenylacetylene
(500 mg, 2.18 mmol) in toluene (8 mL) was added compound 4
(275 mg, 0.54 mmol), PdCl2(PPh3)2 (38 mg, 0.054 mmol), and tri-
ethylamine (3 mL). The resulting suspension was degassed with ar-
gon for 30 min before CuI (21 mg, 0.108 mmol) was added. The
medium was stirred overnight at room temperature. The dark solu-
tion was then extracted with dichloromethane (30 mL), washed
with water, dried (MgSO4), and concentrated in vacuo. The crude
residue was purified by silica gel chromatography (CH2Cl2/petro-
leum ether, 3:1) to afford compound 6 as a yellow powder (0.182 g,
1
ate complex 9 was obtained as a yellow powder (87 mg, 82%). H
NMR (300 MHz, CDCl3): δ = 8.05 (d, J = 2.4 Hz, 1 H, CH Ar),
7.96–7.99 (m, 1 H, CH Ar), 7.94 (d, J = 2.1 Hz, 1 H, CH Ar),
7.71–7.77 (m, 1 H, CH Ar), 7.54–7.58 (m, 4 H, CH Ar), 7.48 (d, J
= 8.1 Hz, 2 H, CH Ar), 7.39 (d, J = 8.1 Hz, 4 H, CH Ar), 1.35 (s,
18 H, CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 160.9, 159.1,
152.0, 149.0, 143.2, 131.7, 131.4, 130.6, 127.9, 127.6, 125.5, 125.3,
119.9, 119.7, 117.2, 116.6, 115.8, 111.9, 106.4, 96.2, 90.0, 86.3, 82.9,
34.9, 31.2 ppm. C37H32BF2NO2 (571.47): calcd. C 77.76, H 5.64,
N 2.45; found C 77.57, H 5.29, N 2.28. MS (EI): m/z (%) = 571.1
(100), 552.1 (35).
1
65%). H NMR (300 MHz, CDCl3): δ = 8.32 (d, J = 2.1 Hz, 1 H,
CH Ar), 7.81 (d, J = 2.4 Hz, 1 H, CH Ar), 7.76–7.81 (m, 1 H, CH
Ar), 7.56–7.62 (m, 1 H, CH Ar), 7.37–7.42 (m, 6 H, CH Ar), 6.61
(d, J = 8.1 Hz, 4 H, CH Ar), 3.31 (t, J = 7.8 Hz, 8 H, CH2), 2.57
(s, 3 H, CH3), 1.55–1.65 (m, 8 H, CH2), 1.32–1.44 (m, 8 H, CH2),
0.99 (t, J = 7.2 Hz, 12 H, CH3) ppm. 13C NMR (100 MHz, CDCl3):
δ = 169.0, 159.3, 150.3, 148.4, 148.2, 141.9, 137.1, 133.1, 133.1,
131.3, 125.6, 124.7, 123.1, 121.2, 121.1, 120.5, 111.2, 111.2, 110.6,
108.1, 108.0, 97.2, 92.4, 85.3, 81.2, 50.7, 29.4, 21.1, 20.4, 14.0 ppm.
HBO Borate Complex 10: To a stirred solution of HBO 8 (100 mg,
0.15 mmol) in freshly distilled dichloromethane (10 mL) was added
BF3·OEt2 (0.11 mL, 0.9 mmol) by syringe under an argon atmo-
sphere. After 5 min, DIEA (0.16 mL, 0.9 mmol) was added, and
the resulting mixture was stirred at room temperature for 1 h. The
crude solution was then filtered through a column of basic Al2O3
(CH2Cl2), and the solvents were evaporated in vacuo. Pure HBO
borate complex 10 was obtained as an orange powder (80 mg,
76%). 1H NMR (300 MHz, CDCl3): δ = 7.99–8.02 (m, 1 H, CH
Ar), 7.97 (d, J = 2.1 Hz, 1 H, CH Ar), 7.91 (d, J = 2.1 Hz, 1 H,
CH Ar), 7.72–7.78 (m, 1 H, CH Ar), 7.56–7.63 (m, 2 H, CH Ar),
7.45 (d, J = 8.7 Hz, 2 H, CH Ar), 7.37 (d, J = 9 Hz, 2 H, CH Ar),
6.59 (d, J = 9 Hz, 4 H, CH Ar), 3.30 (t, J = 7.8 Hz, 8 H, CH2),
1.54–1.64 (m, 8 H, CH2), 1.31–1.43 (m, 8 H, CH2), 0.98 (t, J =
7.2 Hz, 12 H, CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 161.3,
158.6, 149.0, 148.1, 142.7, 133.3, 132.9, 130.8, 127.7, 127.6, 126.3,
117.4, 117.2, 116.7, 111.8, 111.3, 108.6, 108.2, 106.2, 97.7, 91.1,
84.9, 81.7 ppm. C37H32BF2NO2 (571.47): calcd. C 75.73, H 7.06,
N 5.89; found C 75.54, H 6.67, N 5.61. MS (EI): m/z (%) = 713.3
(100), 694.3 (45).
C
47H53N3O3 (707.95): calcd. C 79.74, H 7.55, N 5.94; found C
79.51, H 7.38, N 5.69. MS (EI): m/z (%) = 707.2 (100).
2-(Benzoxazol-2-yl)-4,6-bis{[4-(tert-butyl)phenyl]ethynyl}phenol (7):
Compound 5 (100 mg, 0.18 mmol) was dissolved in a mixture
of MeOH/THF (50:50, 8 mL). Potassium carbonate (245 mg,
18 mmol) was added, and the resulting mixture was stirred at room
temperature for 1 h. The crude solution was extracted with di-
chloromethane (15 mL), washed with water, dried (MgSO4), and
concentrated in vacuo. The crude solid was washed with pentane
to yield HBO 7 as a bright yellow powder (93 mg, 97%). 1H NMR
(300 MHz, CDCl3): δ = 12.29 (s, 1 H, OH), 8.17 (br. s, 1 H, CH
Ar), 7.76 (br. s, 1 H, CH Ar), 7.65–7.71 (m, 1 H, CH Ar), 7.60–
7.65 (m, 1 H, CH Ar), 7.57 (d, J = 8.7 Hz, 2 H, CH Ar), 7.50 (d,
J = 8.1 Hz, 2 H, CH Ar), 7.41 (dd, J = 9 Hz, 6 H, CH Ar), 1.36
(s, 18 H, CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 161.9, 158.9,
151.8, 151.6, 149.2, 139.7, 139.5, 131.6, 131.3, 129.9, 125.9, 125.4,
125.4, 125.3, 120.1, 119.5, 115.0, 113.5, 110.9, 110.8, 95.0, 89.0,
87.2, 83.4, 34.9, 31.2 ppm. C37H33NO2 (523.67): calcd. C 84.86, H
6.35, N 2.67; found C 84.64, H 6.04, N 2.44. MS (EI): m/z (%) =
523.1 (100).
Supporting Information (see footnote on the first page of this arti-
cle): Copies of the 1H NMR and 13C NMR spectra for all com-
pounds and spectroscopic data.
2-(Benzoxazol-2-yl)-4,6-bis{[4-(dibutylamino)phenyl]ethynyl}phenol
(8): Compound 6 (100 mg, 0.14 mmol) was dissolved in a mixture
of MeOH/THF (50:50, 8 mL). Potassium carbonate (195 mg,
14 mmol) was added, and the resulting mixture was stirred at room
temperature for 1 h. The crude solution was extracted with dichlo-
romethane (15 mL), washed with water, dried (MgSO4), and con-
centrated in vacuo. The crude solid was washed with pentane to
yield HBO 8 as a bright yellow powder (92 mg, 95%). 1H NMR
(300 MHz, CDCl3): δ = 12.17 (s, 1 H, OH), 8.11 (d, J = 2.1 Hz, 1
H, CH Ar), 7.76 (d, J = 2.4 Hz, 1 H, CH Ar), 7.72–7.75 (m, 1 H,
CH Ar), 7.60–7.66 (m, 1 H, CH Ar), 7.44 (d, J = 9 Hz, 2 H, CH
Ar), 7.33–7.42 (m, 4 H, CH Ar), 6.60 (d, J = 8.7 Hz, 4 H, CH Ar),
3.30 (t, J = 7.8 Hz, 8 H, CH2), 1.54–1.64 (m, 8 H, CH2), 1.31–1.43
Acknowledgments
Centre National de la Recherche Scientifique (CNRS) is gratefully
acknowledged for providing financial support and research facili-
ties.
[1] a) H. Kobayashi, M. Ogawa, R. Alford, P. L. Choyke, Y. Ur-
ano, Chem. Rev. 2010, 110, 2620–2640; b) T. Ueno, T. Nagano,
Nature Methods 2011, 8, 642–645; c) L. Yuan, W. Lin, K.
Zheng, S. Zhu, Acc. Chem. Res. 2013, DOI: 10.1021/ar300273v.
[2] S. J. Sahl, M. Leutenegger, M. Hilbert, S. W. Hell, C. Eggeling,
Proc. Natl. Acad. Sci. USA 2010, 107, 6829–6834.
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
9